Understanding Ventilator-Associated Pneumonia and Infection Control
Author Information
Author(s): Alp Emine, Voss Andreas
Hypothesis
What are the risk factors and prevention strategies for ventilator-associated pneumonia (VAP) in intensive care units?
Conclusion
Ventilator-associated pneumonia is a significant cause of morbidity and mortality in intensive care units, and effective infection control measures can help reduce its incidence and associated costs.
Supporting Evidence
- VAP is the leading cause of morbidity and mortality in intensive care units.
- The incidence of VAP varies from 7% to 70% in different studies.
- Early initiation of appropriate antibiotics is crucial for prognosis.
- VAP increases hospital costs and length of stay.
Takeaway
Ventilator-associated pneumonia is a serious lung infection that can happen to patients on breathing machines, and keeping everything clean can help prevent it.
Methodology
This review discusses the epidemiology, diagnosis, and infection control measures related to ventilator-associated pneumonia.
Limitations
The review is based on existing literature and may not cover all recent studies or emerging practices.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website